|
Reference number | Author (Year) | Type of study | Time period | Number of women | Cohorts (n) | Type of diabetes | Comparison(s) |
|
[35] | Di Cianni et al. (2008) | Retrospective | to December 31, 2006 | 101 | Glargine (43) NPH (58) | Type 1 DM | Continuous glargine use throughout pregnancy versus cessation of glargine during pregnancy (replaced w/NPH) |
[36] | Egerman et al. (2009) | Retrospective | January 2004 to August 2006 | 114 | Glargine (65) NPH (49) | Pregestational Gestational | Insulin glargine versus NPH |
[37] | Fang et al. (2009) | Retrospective | January 2003 to April 2008 | 112 | Pregestational: glargine (37), NPH (16) Gestational: glargine (15) NPH (44) | Pregestational Gestational | Insulin glargine versus NPH Pregestational versus gestational DM |
[38] | Imbergamo et al. (2008) | Case control | January 2004 to December 2007 | 73 | Glargine (15) NPH (15) Control (43)* | Type 1 DM | Insulin glargine versus NPH Insulin glargine versus control NPH versus control |
[39] | Negrato et al. (2010) | Observational prospective | January 2004 to April 2009 | 138 | Pregestational: glargine (18), NPH (38) Gestational: glargine (37), NPH (45) | Pregestational Gestational | Insulin glargine versus NPH Pregestational versus gestational DM |
[40] | Poyhonen-Alho et al. (2007) | Case control | January 2003 to December 2005 | 91 | Glargine (42) NPH (50) | Type 1 DM | Insulin glargine versus NPH |
[41] | Price et al. (2007) | Case control | January 2002 to December 2005 | 64 | Pregestational: glargine (10), NPH (10) Gestational: glargine (22), NPH (22) | Pregestational (type 1 DM) Gestational | Insulin glargine versus NPH Pregestational versus gestational DM |
[42] | Smith et al. (2009) | Retrospective | January 2000 to December 2005 | 52 | Glargine (27) NPH (25) | Pregestational (type 1+2 DM) Gestational | Insulin glargine versus NPH |
|